China Pharma Holdings (CPHI) EBITDA (2010 - 2026)
China Pharma Holdings (CPHI) reported EBITDA of -$709562.0 for Q1 2026, up 8.8% on a YoY basis from -$652151.6 in Q1 2025, and up 32.05% quarter-over-quarter from -$1.0 million in Q4 2025.
China Pharma Holdings (CPHI) EBITDA (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported EBITDA for 17 years, with the latest figure at -$709562.0 in Q1 2026.
- For the quarter ending Q1 2026, EBITDA rose 8.8% year-over-year to -$709562.0; the trailing twelve-month figure through Mar 2026 stood at -$2.9 million (up 38.83% YoY), and the FY2025 full-year result was -$2.9 million, up 39.93% from the prior year.
- EBITDA for Q1 2026 stood at -$709562.0, up from -$1.0 million in the prior quarter.
- The five-year high for EBITDA was -$270654.0 in Q1 2023, with the low at -$1.5 million in Q2 2022.
- Historically, EBITDA has averaged -$980372.1 across 5 years, with a median of -$980273.0 in 2024.
- Annual changes were most pronounced in 2023 — EBITDA jumped 72.32% — and 2024, when it plunged 261.15%.
- China Pharma Holdings' EBITDA stood at -$1.1 million in 2022, then declined by 2.37% to -$1.1 million in 2023, then fell by 29.03% to -$1.4 million in 2024, then rose by 26.84% to -$1.0 million in 2025, then soared by 32.05% to -$709562.0 in 2026.
- The last three EBITDA figures came in at -$709562.0 (Q1 2026), -$1.0 million (Q4 2025), and -$594147.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -709,562.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -709,562.00 |
| Dec 31, 2025 | -1.04 Mn |
| Sep 30, 2025 | -594,147.00 |
| Jun 30, 2025 | -508,104.00 |
| Mar 31, 2025 | -778,056.00 |
| Dec 31, 2024 | -1.43 Mn |
| Sep 30, 2024 | -980,273.00 |
| Jun 30, 2024 | -1.48 Mn |
| Mar 31, 2024 | -977,467.00 |
| Dec 31, 2023 | -1.11 Mn |
| Sep 30, 2023 | -706,198.00 |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | -270,654.00 |
| Dec 31, 2022 | -1.08 Mn |
| Sep 30, 2022 | -1.39 Mn |
| Jun 30, 2022 | -1.52 Mn |
| Mar 31, 2022 | -977,841.00 |
| Dec 31, 2021 | -836,967.00 |
| Sep 30, 2021 | -864,168.00 |
| Jun 30, 2021 | -641,306.00 |